Příloha č. 21
Seznam léčivých přípravků s obsahem účinné látky erytropoetin pro léčbu germinálních nádorů, ovariálních karcinomů, karcinomu plic, karcinomu prsu, karcinomu čípku, karcinomů v orofaciální oblasti, zhoubných nádorů placenty, mnohočetného myelomu a chronické lymfatické leukémie
+------------------+-------+-----------------------------------------------+----------------------+
| Účinná látka | Kód | Název | Doplněk |
+------------------+-------+-----------------------------------------------+----------------------+
| Erytropoetin | 57340 | EPREX 1 000 IU/0.1ML | INJ 6X0.5ML/5KU+STR |
| +-------+-----------------------------------------------+----------------------+
| | 57341 | EPREX 1 000 IU/0.1ML | INJ 6X0.6ML/6KU+STR |
| +-------+-----------------------------------------------+----------------------+
| | 57342 | EPREX 1 000 IU/0.1ML | INJ 6X0.7ML/7KU+STR |
| +-------+-----------------------------------------------+----------------------+
| | 57343 | EPREX 1 000 IU/0.1ML | INJ 6X0.8ML/8KU+STR |
| +-------+-----------------------------------------------+----------------------+
| | 57344 | EPREX 1 000 IU/0.1ML | INJ 6X0.9ML/9KU+STR |
| +-------+-----------------------------------------------+----------------------+
| | 85530 | EPREX 1000 IU/0.1ML | INJ 6X0.3ML/3KU+STR |
| +-------+-----------------------------------------------+----------------------+
| | 85531 | EPREX 1000 IU/0.1ML | INJ 6X0.4ML/4KU+STR |
| +-------+-----------------------------------------------+----------------------+
| | 85532 | EPREX 1000 IU/0.1ML | INJ 6X1ML/10KU+STR |
| +-------+-----------------------------------------------+----------------------+
| | 85528 | EPREX 200 IU/0.1ML | INJ 6X0.5ML/1KU+STR |
| +-------+-----------------------------------------------+----------------------+
| | 93579 | EPREX 200 IU/0.1ML | INJ 6X1ML/2KU-LAHV. |
| +-------+-----------------------------------------------+----------------------+
| | 85529 | EPREX 400 IU/0.1ML | INJ 6X0.5ML/2KU+STR |
| +-------+-----------------------------------------------+----------------------+
| | 02267 | EPREX 40000 | INJ 1X1ML/40KU-LAHV |
| +-------+-----------------------------------------------+----------------------+
| | 64816 | NEORECORMON 1000 IU | INJ 6X0.3ML/1KU |
| +-------+-----------------------------------------------+----------------------+
| | 58451 | NEORECORMON 10000 IU | INJ 6X0.6ML/10KU |
| +-------+-----------------------------------------------+----------------------+
| | 64812 | NEORECORMON 2000 IU | INJ 6X0.3ML/2KU |
| +-------+-----------------------------------------------+----------------------+
| | 58453 | NEORECORMON 20000 IU | INJ 6X0.6ML/20KU |
| +-------+-----------------------------------------------+----------------------+
| | 64818 | NEORECORMON 3000 IU | INJ 6X0.3ML/3KU |
| +-------+-----------------------------------------------+----------------------+
| | 06221 | NEORECORMON 4000 IU | INJ SOL 6X4000 IU |
| +-------+-----------------------------------------------+----------------------+
| | 64814 | NEORECORMON 500 IU | INJ 6X0.3ML/500UT |
| +-------+-----------------------------------------------+----------------------+
| | 58449 | NEORECORMON 5000 IU | INJ 6X0.3ML/5KU |
| +-------+-----------------------------------------------+----------------------+
| | 58686 | NEORECORMON MULTIDOSE 100000 | INJ SIC 1X100KU+SOL |
| +-------+-----------------------------------------------+----------------------+
| | 58685 | NEORECORMON MULTIDOSE 500000 | INJ SIC 1X50KU+SOLV |
| +-------+-----------------------------------------------+----------------------+
| | 58688 | NEORECORMON PRO RECOPEN 10000 | INJ SIC 3X10KU+SOLV |
| +-------+-----------------------------------------------+----------------------+
| | 58744 | NEORECORMON PRO RECOPEN 20000 | INJ SIC 3X20KU+SOLV |
| +-------+-----------------------------------------------+----------------------+
| | 45355 | RECORMON S 10000 | INJ SIC 5X10KU+STR. |
| +-------+-----------------------------------------------+----------------------+
| | 45354 | RECORMON S 5000 | INJ SIC 5X5KU+STR. |
+------------------+-------+-----------------------------------------------+----------------------+
------------------------------------------------------------------